Diabetes mellitus, in particular type 2 disease, is an increasing health problem associated with poor diet, lack of exercise and the resulting trend towards obesity, especially in the young. Monitoring glycaemic control is of vital importance, and new evidence suggests that fructosamine testing has an importance part to play.
Diabetes mellitus (DM) is a global epidemic, increasing at an alarming rate and burdening healthcare systems.1 According to the World Health Organization (WHO), diabetes is estimated to be the seventh leading cause of mortality, with 1.6 million deaths attributed to diabetes in 2016.2
Numerous clinical studies have highlighted the fact that diabetic complications may be reduced through the long-term monitoring and tight control of blood glucose levels. Both fasting plasma glucose (FPG) and HbA1c tests are universally accepted as reliable measures of diabetes control. However, studies have emerged highlighting the role of fructosamine in diabetes monitoring.
While HbA1c provides an index of glycaemia over two to three months, fructosamine provides this index over the duration of two to three weeks, enabling closer monitoring of diabetic control.1
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
Register
